Skip to main content
Log in

Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: Possible role of dopamine

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Low doses of buspirone, haloperidol and sulpiride were compared with diazepam in two experimental models of anxiety in rats. In a conflict test, 0.6 and 1.2 mg/kg buspirone, 0.05 and 0.10 mg/kg haloperidol and 0.5 mg/kg sulpiride significantly increased punished responding. Buspirone 1.2 and 2.5 mg/kg significantly reduced the number of unpunished responses while haloperidol and sulpiride at the doses tested had no effect. Effects on punished responding were seen in a narrow dose range and were less pronounced with these drugs than with diazepam. Similar results were obtained with rats', activity in the two-compartment exploratory test. At doses causing no change in the locomotion of rats in photocell activity cages, buspirone (0.1 mg/kg), haloperidol (0.025–0.100 mg/kg) and sulpiride (0.5–1.0 mg/kg) significantly increased the number of crossings between the two compartments. Again, the peak effects were small when compared with the effect of diazepam and the active dose range was very narrow. Apomorphine 0.2 mg/kg SC significantly counteracted the effect of 0.1 mg buspirone and 1.0 mg/kg sulpiride in the two-compartment exploratory test with no effect on 2.5 mg/kg diazepam.

The data show that buspirone, in a narrow dose range, shows disinhibitory effects in experimental models of anxiety. Similar effects are shown by low doses of haloperidol and sulpiride. It is suggested that buspirone and sulpiride produce these disinhibitory effects by blocking particular dopamine receptors in the brain, possibly those located in the nerve terminals, but it is likely that other mechanisms, particularly serotonin, are involved in the effects of buspirone in anxious states.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Allen LE, Ferguson H, Cox RH Jr (1974) Pharmacologic effects of MJ 9022–1, a potential tranquilizing agent. Arzneimittelforsch 24:917–922

    Google Scholar 

  • Brinkley JR, Beitman BD, Friedel RO (1979) Low-dose neuroleptic regimens in the treatment of bordeline patients. Arch Gen Psychiatry 36:319–326

    Google Scholar 

  • Caccia S, Muglia M, Mancinelli A, Garattini S (1983) Disposition and metabolism of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in the rat. Xenobiotica 13:147–153

    Google Scholar 

  • Carli M, Samanin R (1982) Evidence that agents increasing water consumption do not necessarily generate “false positives” in conflict procedures using water as a reinforcer. Pharmacol Biochem Behav 17:1–3

    Google Scholar 

  • Carli M, Ballabio M, Caccia S, Garattini S, Samanin R (1981) Studies on some pharmacological activities of 7-nitro-2-amino-5-phenyl-3H-1,5-benzodiazepine (CP 1414 S) in the rat. Arzneimittelforsch 31:1721–1723

    Google Scholar 

  • Cook L, Davidson AB (1973) Effects of behaviorally active drugs in a conflict-punishment procedure in rats. In: Garattini S, Mussini E, Randall LO (Eds) The benzodiazepines. Raven Press, New York, pp 327–345

    Google Scholar 

  • Cimino M, Ponzio F, Achilli G, Vantini G, Perego C, Algeri S, Garattini S (1983) Dopaminergic effects of buspirone, a novel anxiolytic agent. Biochem Pharmacol 32:1069–1074

    Google Scholar 

  • Costall B, Fortune DH, Hui S-CG, Naylor RJ (1980) Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: Drug interaction at the presynaptic receptors? Eur J Pharmacol 63:347–358

    Google Scholar 

  • Costall B, Domeney AM, Naylor RJ (1983) Stimulation of rat spontaneous locomotion by low doses of haloperidol and (-)-sulpiride: Importance of animal selection and measurement technique. Eur J Pharmacol 90:307–314

    Google Scholar 

  • Crawley JN (1981) Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 15:695–699

    Google Scholar 

  • Davidson AB, Cook L (1969) Effects of combined treatment with trifluoperazine-HCl and amobarbital on punished behavior in rats. Psychopharmacologia 15:159–168

    Google Scholar 

  • Di Chiara G, Porceddu ML, Vargiu L, Argiolas A, Gessa GL (1976) Evidence for dopamine receptors mediating sedation in the mouse brain. Nature 264:564–567

    Google Scholar 

  • Di Chiara G, Porceddu ML, Fratta W, Gessa GL (1977) Postsynaptic receptors are not essential for dopaminergic feedback regulation. Nature 267:270–272

    Google Scholar 

  • Eison MS, Eison AS (1984) Buspirone as a midbrain modulator: Anxiolysis unrelated to traditional benzodiazepine mechanisms. Drug Dev Res 4:109–119

    Google Scholar 

  • Eison AS, Eison MS, Reblet LA, Temple DL Jr (1983) Indications of serotoninergic involvement in the actions of a potential nonbenzodiazepine anxiolytic: MJ 13805. Soc Neurosci Abstr 9:436

    Google Scholar 

  • Fabre LF Jr, McLendon DM (1977) A double-blind clinical trial of lenperone in out-patients with anxiety. Curr Ther Res 22:900–908

    Google Scholar 

  • Farnebo LO, Hamberger B (1971) Drug-induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta Physiol Scand Suppl 371:35–44

    Google Scholar 

  • File SE (1984) The neurochemistry of anxiety. In: Burrows GD, Norman TR, Davies B (Eds) Antianxiety agents. Elsevier, Amsterdam, pp 13–32

    Google Scholar 

  • Finnerty RJ, Goldberg HL, Nathan L, Lowrey C, Cole JO (1976) Heloperidol in the treatment of psychoneurotic anxious outpatients. Dis Nerv Syst 37:621–624

    Google Scholar 

  • Garattini S, Caccia S, Mennini T (1985) Buspirone, a novel anxiolytic agent different from benzodiazepines. Actualités Médicales Internationales en Psychiatrie (in press)

  • Goldberg HL, Finnerty RJ (1979) The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am J Psychiatry 136:1184–1187

    Google Scholar 

  • Goldberg ME, Salama AI, Patel JB, Malick JB (1983) Novel nonbenzodiazepine anxiolytics. Neuropharmacology 22:1499–1504

    Google Scholar 

  • Jenner P, Marsden CD (1981) Possible neuronal mechanisms involved in the production of the disinhibitory action of sulpiride. Adv Biol Psychiatry 7:100–102

    Google Scholar 

  • Laville C, Margarit J (1968) Influence du sulpiride sur l'activité et la vigilance chez la souris. Pathol Biol (Paris) 16:663–665

    Google Scholar 

  • Mattila MJ, Aranko K, Seppala T (1982) Acute effects of buspirone and alcool on psychomotor skills. J Clin Psychiatry 43:12 (Sec. 2) 56–60

    Google Scholar 

  • McMillen BA, Matthews RT, Sanghera MK, Shepard PD, German DC (1983) Dopamine receptor antagonism by the novel antianxiety drug, buspirone. J Neurosci 3:733–738

    Google Scholar 

  • Montanaro N, Vaccheri A, Dall'Oglio R, Gandolfi O (1983) Time course of rat motility response to apomorphine: A simple model for studying preferential blockade of brain dopamine receptors mediating sedation. Psychopharmacology 81:214–219

    Google Scholar 

  • Oakley N, Jones BJ (1983) Buspirone enhances [3H]flunitrazepam binding in vivo. Eur J Pharmacol 87:499–500

    Google Scholar 

  • Raymond MJ, Lucan CJ, Beesley ML, O'Connell BA, Roberts JAF (1957) A trial of five tranquilizing drugs in psychoneurosis. Br Med J 2:63–66

    Google Scholar 

  • Riblet LA, Taylor DP, Eison MS, Stanton HC (1982) Pharmacology and neurochemistry of buspirone. J Clin Psychiatry 43:12 (Sec. 2) 11–16

    Google Scholar 

  • Rickels K, Waissman K, Norstad N, Singer M, Stoltz D, Brown A, Danton J (1982) Buspirone and diazepam in anxiety: A controlled study. J Clin Psychiatry 43:12 (Sec. 2) 81–86

    Google Scholar 

  • Rogerson R, Butler JK (1971) Assessment of low dosage haloperidol in anxiety states. Br J Psychiatry 119:169–170

    Google Scholar 

  • Sanger DJ (1985) GABA and behavioral effects of anxiolytic drugs. Life Sci 36:1503–1513

    Article  CAS  PubMed  Google Scholar 

  • Sanger DJ, Joly D, Zivkovic B (1985) Bahavioral effects of nonbenzodiazepine anxiolytic drugs: A comparison of CGS 9896 and zoplicone with chlordiazepoxide. J Pharmacol Exp Ther 232:831–837

    Google Scholar 

  • Stanton HC, Taylor DP, Riblet LA (1981) Buspirone. An anxioselective drug with dopaminergic action. In: Chronister RB, DeFrance JF (Eds) The neurobiology of the nucleus accumbens. Haer Institute, Brunswick, ME, pp 316–321

    Google Scholar 

  • Tallman JF, Paul SM, Skolnick P, Gallager DW (1980) Receptors for the age of anxiety: Pharmacology of the benzodiazepines. Science 207:274–281

    Google Scholar 

  • Taylor DP, Hyslop DK, Riblet LA (1980) Buspirone: A model for anxioselective drug action. Soc Neurosci Abstr 6:791

    Google Scholar 

  • Taylor DP, Riblet LA, Stanton HC (1983) Dopamine and anxiolytics. In: Malick JB, Enna SJ, Yamamura HI (Eds) Anxiolytics: Neurochemical, behavioral and clinical perspectives. Raven Press, New York, pp 77–87

    Google Scholar 

  • Thiebot MH, Hamon M, Soubrié P (1982) Attenuation of induced-anxiety in rats by chlordiazepoxide: Role of raphe dorsalis benzodiazepine binding site and serotoninergic neurons. Neuroscience 7:2287–2294

    Google Scholar 

  • Thiebot MH, Hamon M, Soubrié P (1983) The involvement of nigral serotonin innervation in the control of punishment-induced behavioral inhibition in rats. Pharmacol Biochem Behav 19:225–229

    Google Scholar 

  • Tissari AH, Stefanini E, Gessa GL (1979) Stimulation of dopamine synthesis and activation of tyrosine hydroxylase by (-)sulpiride, sultopride and tiapride. In: Spano PF, Trabucchi M, Corsini GU, Gessa GL (Eds) Sulpiride and other benzamides. Italian Brain Research Foundation Press, Milan, pp 3–9

    Google Scholar 

  • Tompkins EC, Clemento AJ, Taylor DP, Perhach JL Jr (1980) Inhibition of aggressive behavior in rhesus monkeys by buspirone. Res Commun Psychol Psychiatr Behav 5:337–351

    Google Scholar 

  • Toru M, Moriya H, Yamamoto K, Shimzono Y (1976) A doubleblind comparison of sulpiride with chlordiazepoxide in neurosis. Folia Psychiatr Neurol Jpn 30:153–164

    Google Scholar 

  • Vischer TJ (1957) Clinical study of prochlorperazine, new tranquilizer for treatment of non-hospitalized psychoneurotic patients. N Engl J Med 256:26–27

    Google Scholar 

  • Vogel JR, Beer B, Clody DE (1971) A simple and reliable conflict produce for testing anti-anxiety agents. Psychopharmacologia 21:1–7

    Google Scholar 

  • Weissman BA, Barret JE, Brady LS, Witkin JM, Mendelson WB, Paul SM, Skolnick P (1984) Behavioral and neurochemical studies on the anticonflict actions of buspirone. Drug Dev Res 4:83–93

    Google Scholar 

  • Wise RA (1980) Action of drugs of abuse on brain reward systems. Pharmacol Biochem Behav 13 suppl 1:213–223

    Google Scholar 

  • Wu Y-H, Rayburn JW, Allen LE, Ferguson HC, Kissel JW (1972) Psychosedative agents. 2. 8-(4-substituted 1-piperazinylalkyl)-8-azospiro [4.5] decane-7.9-diones. J Med Chem 15:477–479

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pich, E.M., Samanin, R. Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: Possible role of dopamine. Psychopharmacology 89, 125–130 (1986). https://doi.org/10.1007/BF00175204

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00175204

Key words

Navigation